Clinical Trial Update: A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase I/IIa clinical trial evaluating Cerebraca Wafer in combination with adjuvant temozolomide for patients with recu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Cerebraca Wafer
• Temozolomide (Temozolomide)

Snippet

Sponsor: Everfront Biotech Co., Ltd. | Conditions: Recurrent GBM | Phase 1, Phase 2 | Status: COMPLETED